IDEAYA Biosciences is a precision medicine oncology company focused on developing targeted therapeutics for patients selected using molecular diagnostics. They have multiple products in various stages of clinical trials for different cancers with defined biomarkers based on genetic mutations or molecular signatures. IDEAYA Biosciences has research collaborations and partnerships with Cancer Research UK, the University of Manchester, Pfizer Inc., and GlaxoSmithKline plc.